Bloomberg analyst: 14 counterfeit products related ETFs await SEC approval in the next 12 months

Bloomberg ETF analyst Eric Balchunas said there are 14 counterfeit products ETFs awaiting SEC approval in the next 12 months, including funds that offer exposure to SOL, XRP, HBAR, LTC, asset baskets, and BTC and ETH. In addition, Balchunas expects counterfeit products ETF applications to triple in the next two months.